MSB 3.13% 99.0¢ mesoblast limited

Ann: Update on Scheduled FDA Advisory Committee Meeting, page-112

  1. 2,124 Posts.
    lightbulb Created with Sketch. 45
    FDA says...Topic for Discussion #2: The primary endpoint results in MSB-GVHD001 were statisticallysignificant, the measured response was durable (median 54 days), and the study results wereconsistent across subpopulations and secondary efficacy endpoints.

    I would highlight the above..

    The problem is the 2 previous studies from 10 years ago which it seems the OCDAC is weighting equally.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.0¢
Change
0.030(3.13%)
Mkt cap ! $1.130B
Open High Low Value Volume
96.5¢ $1.03 96.5¢ $4.704M 4.708M

Buyers (Bids)

No. Vol. Price($)
6 87395 98.5¢
 

Sellers (Offers)

Price($) Vol. No.
$1.00 274051 2
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.